We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

This study has been terminated.
(Low enrollment)
ClinicalTrials.gov Identifier:
First Posted: January 20, 2012
Last Update Posted: July 2, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Creighton University
The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.

Condition Intervention Phase
Atrial Fibrillation Medication Adherence Other: Education and telephone follow-up Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Pilot Project to Determine Rates and Reasons for Non-Adherence in Patients Receiving Chronic Oral Antiarrhythmic Therapy for Atrial Fibrillation in the State of Nebraska

Resource links provided by NLM:

Further study details as provided by Creighton University:

Primary Outcome Measures:
  • Adherence to anti-arrhythmic medication [ Time Frame: 1 year ]
    Assessing whether patients stop taking anti-arrhythmic medication without instruction to do so by their physician.

Enrollment: 9
Study Start Date: January 2012
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Phone follow-up
All study participants will be receiving education and monthly telephone follow-up.
Other: Education and telephone follow-up
Education related to anti-arrhythmic therapy and monthly telephone follow-up to assess adherence to medication.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Prescribed a new anti-arrhythmic medication for atrial fibrillation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01513031

United States, Nebraska
Bryan LGH
Lincoln, Nebraska, United States, 68506
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska, United States, 68124
Creighton University
Omaha, Nebraska, United States, 68178
Sponsors and Collaborators
Creighton University
Principal Investigator: Dan Hilleman, PharmD Creighton University
  More Information

Responsible Party: Creighton University
ClinicalTrials.gov Identifier: NCT01513031     History of Changes
Other Study ID Numbers: DRONE_L_06034
11-16223 ( Other Identifier: Institutional Review Board )
First Submitted: January 16, 2012
First Posted: January 20, 2012
Last Update Posted: July 2, 2012
Last Verified: June 2012

Keywords provided by Creighton University:
Atrial fibrillation
Anti-arrhythmic medication
Medication adherence

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes
Anti-Arrhythmia Agents